recombinant human factor VIII (rhFVIII) / ProFactor Pharma - LARVOL DELTA

Scots biotech firm gets £1.1m lift for lifeline haemophilia research (The National) - "ProFactor Pharma (PFP) has received £1.1 million in the second tranche of support from its £2m funding round announced in September last year to advance its research and development programme....'They are ahead of our expectations giving us greater confidence as we move towards toxicology studies in Q4 this year, prior to entering clinical trials and a Series A funding round next year.'...'The test results are an incredibly encouraging development for the company, everyone active in the field of haemophilia research...' "

Financing • Preclinical • Hemophilia